InterRoid

InterRoid was founded in 2012 as DaVinci Lab, changed its name to AIDER Nutrizine after merging with AIDER in 2020, and listed on the KONEX market in November 2022. In April 2025 it renamed itself InterRoid, redefining its business identity around AI.

The company has developed and supplied integrated AI solutions such as MLOps and AI image and video analysis, alongside a health-supplement distribution business.

More recently it has focused on 'SeiRen,' a next-generation voice automation solution that integrates generative AI, speech recognition (STT), and speech synthesis (TTS) technology, supplying chatbot and callbot services to the financial, insurance, and public sectors.

In September 2025 the company unveiled a new Agentic AI platform specialized for HR recruitment processes, built on its SeiRen AI platform.

In October of the same year it obtained a facilities-less telecommunications carrier license and secured the legal basis to provide telecom services directly to enterprise, franchise, and institutional customers by leasing lines from major carriers such as KT and SK Telecom.

The company stated it is phasing down its R&D-heavy bio segment and transforming the organization to focus on AI.

A substantial portion of its workforce is reported to be skilled personnel with domestic and international master's or doctoral degrees in AI, and competitively it operates in a space that overlaps with numerous domestic AI chatbot, callbot, and contact-center-specialized IT firms.

Based on the most recently confirmed annual (2022, consolidated) filing with Korea's Financial Supervisory Service, revenue was KRW 7.28 billion and the operating loss was KRW 1.34 billion, translating into an operating margin of -18.4%.

The net loss was KRW 0.98 billion, of which KRW 0.93 billion was attributable to owners. Operating cash flow for the same period was -KRW 1.01 billion, indicating cash outflow from operations as well.

Total equity stood at KRW 16.13 billion (KRW 15.99 billion attributable to owners) against total liabilities of KRW 10.78 billion, for a debt ratio of 66.8%.

These figures reflect the period immediately following the November 2022 KONEX listing, when the company still ran health-supplement distribution alongside AI solutions. Subsequent quarterly results are not provided within a separately confirmed disclosure window and are therefore not addressed in this report.

However, according to financial-data providers, on a separate (non-consolidated) basis, FY2024 revenue rose 13.1% year-on-year while the operating loss widened 5.5% and the net loss widened 211%, suggesting that revenue growth and profitability recovery did not move in tandem.

The same source explained that despite an economic slowdown, corporate investment in AI-based automation solutions expanded on the back of labor-cost reduction and 24/7 customer-service demand, driving revenue growth, though R&D spending kept profitability limited.

As these figures fall outside the confirmed financial scope (annual 2022) used in this report, they should be treated as provisional reference data interpreted only as separate-basis, year-on-year ratios.

South Korea's domestic AI market was valued at KRW 2.6 trillion in 2023, growing 17.2% year-on-year, and is projected to grow at a 14.9% CAGR over the following five years to reach KRW 4.4 trillion by 2027. According to Gartner, the AI-based work-automation market is expected to grow at over 35% annually through 2030.

This growth stems from a structure in which corporate labor-cost reduction and demand for round-the-clock customer service combine to expand demand for contact-center and consultation automation.

The voice AI/callbot market in which InterRoid operates is fairly crowded, mixing large-corporation-affiliated system integrators, telecom-affiliated subsidiaries, and numerous startups.

The facilities-less telecom carrier license the company secured in 2025 could serve as a differentiator by allowing it to bundle callbot services with telecom services, though other players preparing similar bundled offerings cannot be ruled out.

The domestic contact-center/consultation-automation market is still assessed to be in an early diffusion stage without a clearly standardized billing model or dominant operator.

Remaining on the KONEX market may put the company at a relative disadvantage versus KOSDAQ-listed competitors in terms of capital-raising capacity and brand recognition.

Following its name change, the company formalized a strategy of reducing its bio-segment weighting and concentrating resources on AI voice and callbot business. In September 2025, based on its SeiRen platform, it stated it had successfully completed deployment of the platform at a leading domestic HR company.

In October of the same year, it announced it had officially obtained a facilities-less telecommunications carrier license and would move into the AI-based voice-communication services market.

The company outlined plans to gradually expand services starting with industries that handle heavy phone-consultation volumes, such as insurance, hospitals, academies, retail, and public institutions.

In media interviews, company representatives said they were exploring overseas expansion into Japan and Southeast Asia while significantly strengthening R&D in lightweight Physical AI for robots and digital devices.

The company also indicated it was pursuing an aggressive growth strategy aimed at turning operating profit positive starting this year, though this is a target stated by the company itself and has not been verified through a confirmed audit report.

Given the company's KONEX listing status, the timing of future periodic business and audit reports will likely be the key indicator for gauging whether these targets are achieved.